sumatriptan has been researched along with Dyskinesia Syndromes in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using [3H]sumatriptan as a radioligand, 5-hydroxytryptamine (5-HT)1B receptors were examined in posterior striatum and midbrain post-mortem tissue sections of 12 patients who had died from representative degenerative movement disorders as compared to nine controls." | 3.70 | 5-HT1B receptor binding in degenerative movement disorders. ( Berciano, J; Castro, ME; Figols, J; Pascual, J; Pazos, A; Romón, T, 1998) |
| "Serotonin syndrome has been reported exclusively in patients on medications for psychiatric illness and Parkinsonism, despite the fact that the putative action of many antimigraine agents also involves the serotonin system." | 1.29 | Serotonin syndrome complicating migraine pharmacotherapy. ( Lucker, C; Mathew, NT; Tietjen, GE, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathew, NT | 1 |
| Tietjen, GE | 1 |
| Lucker, C | 1 |
| Castro, ME | 1 |
| Pascual, J | 1 |
| Romón, T | 1 |
| Berciano, J | 1 |
| Figols, J | 1 |
| Pazos, A | 1 |
2 other studies available for sumatriptan and Dyskinesia Syndromes
| Article | Year |
|---|---|
Serotonin syndrome complicating migraine pharmacotherapy.
Topics: Adult; Autonomic Nervous System Diseases; Dihydroergotamine; Drug Synergism; Female; Gastrointestina | 1996 |
5-HT1B receptor binding in degenerative movement disorders.
Topics: Aged; Aged, 80 and over; Corpus Striatum; Female; Humans; Huntington Disease; Male; Middle Aged; Mov | 1998 |